Atlas Trials

SAfety of Regional Citrate Anticoagulation (SARCA Study)

Clinical trial NCT05339139 · RECRUITING

Trial details

NCT number
NCT05339139
Sponsor
Fresenius Medical Care North America
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Kidney InjuryESRD
Start date
2023-10-17
Primary completion
2025-04-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.